- This event has passed.
A Closer Look: Clinical Trials and the PRESIDIO Study
February 27 @ 2:00 pm - 3:00 pm ESTFree
Join MSU together with Kezar Life Sciences for A Closer Look: Clinical Trials and the PRESIDIO Study.
Clinical trials are a key research tool for advancing medical knowledge and patient care. Join Kezar Life Sciences as Dr. Richard Leff provides an overview of the clinical trial process, their importance in research and bringing new therapies to the market. Dr. Leff will also share information around the PRESIDIO Study, a phase 2 clinical study currently evaluating the use of KZR-616, a selective immunoproteasome inhibitor for the treatment of polymyositis and dermatomyositis.
Learn more about the PRESIDIO Study here.
About joining this webinar
REGISTRATION IS REQUIRED for this free webinar. Click the Register button above to get started. After registration, you will receive an email containing all of the information you need to join the webinar on the scheduled time and date. Be sure to check your spam and junk folders if you do not see the email.
Presenting during the webinar:
Richard Leff, M.D.
For the past 10 years I have been an independent consultant in rheumatology and biopharmaceutical clinical development. In my chosen profession of developing new drugs, prior to that I had 15 years of leading and managing teams in the international clinical development of novel pharmaceutical compounds for the treatment of rheumatologic (mainly arthritis) and other diseases, in the US and around the world. I have worked with other, external groups, such as the NIH Osteoarthritis Initiative Consortium, OMERACT, IMMPACT, and the OARSI FDA Osteoarthritis Guidelines Initiative. I have also served as the pharmaceutical industry representative on FDA advisory committees on Arthritis and on Anesthetic and Analgesic Drug Products.
After my rheumatology fellowship, I was a faculty member for 3 years at the Medical University of South Carolina, Charleston, South Carolina in the Division of Rheumatology and Immunology, and was the Chief, Section of Rheumatology, VAMC-Charleston, SC (I was the only Rheumatologist at the VA). During my fellowship at National Institutes of Health, NIAMS, Arthritis and Rheumatism Branch, mainly in the laboratory of Paul Plotz working on myositis and was involved with the care of patients with myositis and lupus nephritis.